Vahanian & Associates Financial Planning Inc. CRSP Holdings History
Vahanian & Associates Financial Planning Inc.'s CRISPR Therapeutics AG Holding Summary
As of 2023-12-31, Vahanian & Associates Financial Planning Inc. held 4,575.00 shares of CRISPR Therapeutics AG(CRSP), totaling $286,400.00. This investment constitutes 1.15% of their stock portfolio, and Vahanian & Associates Financial Planning Inc. now holds 0.01% of the outstanding CRISPR Therapeutics AG(CRSP) stock.
The initial trade took place in 2023Q4. And since then Vahanian & Associates Financial Planning Inc. has made 1 purchases of CRSP, at an average price of $55.02, for a total of 4,575.00 shares. Based on historical transaction data and CRSP's current price of $65.13, Vahanian & Associates Financial Planning Inc.'s estimated gain on his CRSP holdings is $46,253.25, reflecting a 18.38% gain to date.
Vahanian & Associates Financial Planning Inc. CRSP ($65.13) Holding Chart
Vahanian & Associates Financial Planning Inc. CRSP ($65.13) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
